Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.

Eratne D, Collins S, Nestor PJ, Pond D, Velakoulis D, Yates M, Masters CL

Open source

DOI
10.3389/fpsyt.2024.1488494
Published
2024
Container
Frontiers in psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2024.1488494,
  title = {Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.},
  author = {Eratne D and Collins S and Nestor PJ and Pond D and Velakoulis D and Yates M and Masters CL},
  year = {2024},
  journal = {Frontiers in psychiatry},
  doi = {10.3389/fpsyt.2024.1488494},
  url = {https://doi.org/10.3389/fpsyt.2024.1488494}
}

RIS

TY  - JOUR
TI  - Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.
AU  - Eratne D
AU  - Collins S
AU  - Nestor PJ
AU  - Pond D
AU  - Velakoulis D
AU  - Yates M
AU  - Masters CL
PY  - 2024
JO  - Frontiers in psychiatry
DO  - 10.3389/fpsyt.2024.1488494
UR  - https://doi.org/10.3389/fpsyt.2024.1488494
ER  - 

APA

D, E., S, C., PJ, N., D, P., D, V., M, Y., & CL, M. (2024). Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2024.1488494

Source records